121 related articles for article (PubMed ID: 34119144)
1. The structure elucidation of novel arabinogalactan LRP1-S2 against pancreatic cancer cells growth in vitro and in vivo.
He F; Zhang S; Li Y; Chen X; Du Z; Shao C; Ding K
Carbohydr Polym; 2021 Sep; 267():118172. PubMed ID: 34119144
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural characterization of a pectin from Lycium ruthenicum Murr and its anti-pancreatic ductal adenocarcinoma cell activity.
Zhang S; He F; Chen X; Ding K
Carbohydr Polym; 2019 Nov; 223():115104. PubMed ID: 31426957
[TBL] [Abstract][Full Text] [Related]
3. Arabinogalactan derived from Lycium barbarum fruit inhibits cancer cell growth via cell cycle arrest and apoptosis.
Gong G; Liu Q; Deng Y; Dang T; Dai W; Liu T; Liu Y; Sun J; Wang L; Liu Y; Sun T; Song S; Wang Z; Huang L
Int J Biol Macromol; 2020 Apr; 149():639-650. PubMed ID: 31991207
[TBL] [Abstract][Full Text] [Related]
4. HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway.
Yao Y; Zhou L; Liao W; Chen H; Du Z; Shao C; Wang P; Ding K
Carbohydr Polym; 2019 Jan; 204():111-123. PubMed ID: 30366522
[TBL] [Abstract][Full Text] [Related]
5. A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by inducing apoptosis and suppressing autophagy.
Bian Y; Zeng H; Tao H; Huang L; Du Z; Wang J; Ding K
Int J Biol Macromol; 2020 Nov; 162():107-115. PubMed ID: 32531363
[TBL] [Abstract][Full Text] [Related]
6. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
[TBL] [Abstract][Full Text] [Related]
7. Solasodine, Isolated from
Fan Y; Li Z; Wu L; Lin F; Shao J; Ma X; Yao Y; Zhuang W; Wang Y
Drug Des Devel Ther; 2021; 15():1509-1519. PubMed ID: 33888977
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
Wang Y; Wu X; Zhou Y; Jiang H; Pan S; Sun B
Cancer Prev Res (Phila); 2016 Mar; 9(3):234-44. PubMed ID: 26667450
[TBL] [Abstract][Full Text] [Related]
9. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
10. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
11. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
12. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.
Chen H; Sun B; Pan S; Jiang H; Sun X
Anticancer Drugs; 2009 Feb; 20(2):131-40. PubMed ID: 19209030
[TBL] [Abstract][Full Text] [Related]
14. The main anthocyanin monomer of Lycium ruthenicum Murray induces apoptosis through the ROS/PTEN/PI3K/Akt/caspase 3 signaling pathway in prostate cancer DU-145 cells.
Li ZL; Mi J; Lu L; Luo Q; Liu X; Yan YM; Jin B; Cao YL; Zeng XX; Ran LW
Food Funct; 2021 Feb; 12(4):1818-1828. PubMed ID: 33527955
[TBL] [Abstract][Full Text] [Related]
15. Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer.
Luo Q; Li Z; Yan J; Zhu F; Xu RJ; Cai YZ
J Med Food; 2009 Aug; 12(4):695-703. PubMed ID: 19735167
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with interleukin-15 and metformin as a synergistic treatment for pancreatic cancer.
Shi L; Wen J; Zhang W; Meng FD; Wan Y; Wang L; Zhang L; Zhu HY
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5075-5089. PubMed ID: 34486682
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
Ali S; Banerjee S; Schaffert JM; El-Rayes BF; Philip PA; Sarkar FH
J Cell Biochem; 2010 May; 110(1):171-81. PubMed ID: 20213764
[TBL] [Abstract][Full Text] [Related]
19. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
